drugset / Trial / NCT00484822
Bemiparin Randomized Trial on Bridging Oral Anticoagulants in Invasive Procedures (BERTA Study)
RandomizedParallel-groupDouble-blindTreatment
Summary
Often it is necessary to temporarily discontinue OAT when surgical or other invasive procedures are required. However, there is no consensus on the optimal management in these situations, and heparin bridging therapy is the current usual practice in these situations. No large randomized, controlled clinical trials have been yet performed to evaluate the efficacy and safety of a low molecular weight heparins (LMWH) as bridging therapy.
Timeline
- Start
- 2007-02
- Primary completion
- —
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bemiparin | Other / unclassified | 3500 iu | Subcutaneous |
| Comparator | Heparina | Unknown | 10000 iu | — |
Indications
No indication recorded.